Sectors

Telkom Indonesia’s MDI Ventures unit has helped the e-commerce shipping platform complete its latest round, following an earlier tranche in December.

Returning investor Leaps by Bayer was among the participants in the cell-based immunotherapy developer’s series C round having previously led a $250m round in 2019.

Heritage Medical Systems and AbbVie Ventures took part in genome editing technology developer Caribou Biosciences' first funding round in five years.

Funds managed by BlackRock added $40m to the $60m supplied for the drug development technology developer by investors including Novo, Evotec and Bristol Myers Squibb in May.

Biox Biosciences, Novo, Sanofi and Merck & Co are all in line to exit the immuno-oncology therapy developer, which has filed for a $100m initial public offering.

UC Berkeley-founded genome editing technology developer Caribou Biosciences has completed its first funding round in five years.

BlackRock has joined the University of Dundee spinout’s series C round, following a $60m first close in May last year.

The utility engagement software provider secured the funding in a round co-led by Schneider Electric and AES Corporation at a $1.5bn valuation.

Ceres, Dai Nippon Printing, Japan Post Investment, Money Forward, TIS and Toppan all backed the business development, incubation and investment company's latest round.

The database platform developer will embark on international expansion with funding raised from investors including Dell Technologies Capital and Wipro Ventures.

Merck & Co is set to exit the genomic services and cancer diagnostics provider in an acquisition by Bio-Techne potentially sized at $320m.